Integrated DR-TB Algorithm
H5ContentEligibility Criteria for BPaLM
H5ContentRelative contraindications Criteria for BPaLM
H5ContentShorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Eligibility Criteria
H5ContentPre-treatment Evaluation [PTE] of DR-TB Patients​
H5ContentTB Disease Severity considerations for Management
H5ContentTreatment initiation for MDR/RR-TB cases
H5ContentOverview of Treatment Course for patients on BPaLM regimen
H5ContentManagement of BPaLM ineligible patients
H5ContentRegimen modification for patients on BPaLM regimen
H5ContentImplementation Consideration for BPaLM regimen
H5ContentExtension criterion for BPaLM regimen
H5ContentScreening of patients on BPaLM regimen for Linezolid toxicity
H5ContentFollow-up monitoring of BPaLM
H5ContentFollow-up monitoring of modified shorter oral MDR/RR-TB regimen with Lzd
H5ContentRegimen Modification of Shorter Oral MDR/RR regimen containing Bdq and Lnz
H5ContentPrinciples of Switching from BpalL/ Shorter Oral Regimen to Longer Oral Regimen
H5ContentRefreshing BDQ course after switching between regimens
H5Content
Cover
This chapter discusses the details regarding the various updates with respect to BPaLM regimen and other updates regarding the shorter-oral and longer-oral regimen.